Every open market buy and sale of Precision Biosciences Inc stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are net sellers over the last 12 months: $63K bought and $459K sold.
Buying and selling by month
open market, last 12 monthsGet an alert when DTIL insiders trade
We read every Form 4 the moment the SEC posts it and tell you when an DTIL officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.
Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.
Every DTIL insider trade
2 years · newest first| Insider | Type | Price | Held after | Filed | |||
|---|---|---|---|---|---|---|---|
| Nov 10, 2026 | Dario ScimecaChief Legal Officer | Sale plan | 2,821 | $9.75 | $28K | 56,782 | Nov 12Form 4 |
| Sep 28, 2026 | Stanley FrankelDirector | Buy | 1,000 | $6.00 | $6K | 41,478 | Sep 30Form 4 |
| Sep 25, 2026 | Geno J GermanoDirector | Buy | 2,609 | $6.28 | $16K | 47,492 | Sep 29Form 4 |
| Sep 25, 2026 | Melinda BrownDirector | Buy | 1,135 | $6.27 | $7K | 45,481 | Sep 29Form 4 |
| Feb 18, 2026 | J. Jefferson SmithChief Research Officer | Sale plan | 4,925 | $3.84 | $19K | 121,926 | Feb 19Form 4 |
| Feb 18, 2026 | Dario ScimecaGeneral Counsel and Secretary | Sale plan | 4,925 | $3.84 | $19K | 56,457 | Feb 19Form 4 |
| Feb 18, 2026 | John Alexander KellyCFO | Sale plan | 8,149 | $3.84 | $31K | 125,883 | Feb 19Form 4 |
| Feb 18, 2026 | Michael AmorosoPresident and CEO | Sale plan | 20,559 | $3.84 | $79K | 243,392 | Feb 19Form 4 |
| Jan 22, 2026 | Michael AmorosoPresident and CEO | Sale plan | 34,799 | $4.17 | $145K | 196,154 | Jan 22Form 4 |
| Jan 21, 2026 | J. Jefferson SmithChief Research Officer | Sale plan | 10,200 | $4.03 | $41K | 110,184 | Jan 22Form 4 |
| Jan 21, 2026 | John Alexander KellyCFO | Sale plan | 15,213 | $4.03 | $61K | 106,448 | Jan 22Form 4 |
| Jan 21, 2026 | Dario ScimecaGeneral Counsel and Secretary | Sale plan | 8,854 | $4.03 | $36K | 44,715 | Jan 22Form 4 |
| Dec 16, 2025 | Stanley FrankelDirector | Buy | 2,700 | $4.70 | $13K | 19,478 | Dec 17Form 4 |
| Dec 16, 2025 | Geno J GermanoDirector | Buy | 3,000 | $4.72 | $14K | 23,883 | Dec 17Form 4 |
| Dec 15, 2025 | Melinda BrownDirector | Buy | 1,381 | $4.97 | $7K | 23,346 | Dec 17Form 4 |
DTIL insider trading FAQ
Are DTIL insiders buying or selling?
Insiders are net sellers over the last 12 months. 3 insiders bought $63K of DTIL on the open market in 6 trades, and 4 sold $459K in 9 trades, 100% of that under pre-arranged trading plans.
When did an DTIL insider last buy shares?
Stanley Frankel (Director) bought 1,000 shares for $6K on Sep 28, 2026, reported on Sep 30, 2026.
When did an DTIL insider last sell shares?
Dario Scimeca (Chief Legal Officer) sold 2,821 shares for $28K on Nov 10, 2026, under a pre-arranged trading plan.
What is a Form 4?
Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.
Why do insider sales matter less than buys?
Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.
From SEC Form 4 filings · Not investment advice
